Aderis Pharmaceuticals Inc., of Hopkinton, Mass., appointed Paul Greengard to its scientific advisory board.
Advanced Neuromodulation Systems Inc., of Dallas, named Kenneth Hawari general counsel and executive vice president, corporate development.
Advanced Viral Research Corp., of Yonkers, N.Y., established a scientific advisory board consisting of George Canellos, Michael Harris, James D’Olimpio and Carol Armenti.
Anadys Pharmaceuticals Inc., of San Diego, appointed David Kramer chief financial officer, Elizabeth Reed director of legal affairs, Brad Kerr senior director of clinical affairs and Wei Liaw associate director of pharmaceutical development.
Athenix Corp., of Research Triangle Park, N.C., appointed Greg Lewis vice president, business development, and Cindy Skocik director of finance.
Atrix Laboratories Inc., of Fort Collins, Colo., appointed Stephen Warren vice president of research and development.
Cambrex Corp., of East Rutherford, N.J., appointed Daniel Marshak vice president and chief technology officer, biotechnology, and Ron Carroll vice president and chief technology officer, pharmaceutical technologies.
Celsion Corp., of Columbia, Md., appointed William Gannon vice president, clinical affairs, medical director.
Cepheid Inc., of Sunnyvale, Calif., elected Robert Easton to its board.